Skip to content

LivaNova LIVN Cash ratio

Cash ratio at other companies

Abbott logo
AbbottABT
0.4×-0.1×
Haemonetics logo
HaemoneticsHAE
0.9×+0.3×
Medtronic logo
MedtronicMDT
0.2×0.0×
ResMed logo
ResMedRMD
1.2×+0.2×
Boston Scientific logo
Boston ScientificBSX
0.2×+0.1×
Stryker logo
StrykerSYK
0.5×+0.2×

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on the most recent quarter.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's cash ratio?
LivaNova (LIVN) reported cash ratio of 0.7× in Q1 2026.
How has LivaNova's cash ratio changed year-over-year?
LivaNova's cash ratio decreased by 28.9% year-over-year, from 1× to 0.7×.
What is the long-term trend for LivaNova's cash ratio?
Over 5 years (2020 to 2025), LivaNova's cash ratio has grown at a -0.8% compound annual growth rate (CAGR), from 0.8× to 0.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.